Arkolith/Insider Trading/NDRA/Form 4/A

UBS Group AG

InsiderENDRA Life Sciences Inc. (NDRA) · full profile →Form 4/A · filed Sep 5, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 27, 2024Buy(P)0—$0146K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001610520-24-000153) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML

Keep exploring

Connected pages for ENDRA Life Sciences Inc.

Build

Ask your agent about NDRA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001610520-24-000153"
Ask your agent
Use Arkolith to summarize insider buying and selling at ENDRA Life Sciences Inc.
over the last 90 days and cite the filings.